William Ringo

William Ringo

Fortune : 57 115 $ au 31/05/2026

80 ans
Health Technology
Finance
Health Services

Profil

William R.
Ringo
is Chairman at Assembly Biosciences, Inc. since 2015, Chairman at Sensei Biotherapeutics, Inc. since 2022, Director at Marcadia Biotech, Inc., Non-Executive Director at Atlantic Healthcare Plc since 2017, Director at Indiana University Health Foundation, Inc., Director at Encore Retail GP LLC since 2014, Director at Kovina Therapeutics, Inc. since 2021, and Venture Partner at InCube Venture Partners LLC.
Former roles include President & Chief Executive Officer at Abgenix, Inc. from 2004 to 2006, Non-Executive Chairman & Chief Executive Officer at InterMune, Inc. in 2003, Chairman at Community Health Systems, Inc. from 1994 to 2002, Chairman at Five Prime Therapeutics, Inc. from 2020 to 2021, Chairman at Hyperion Therapeutics, Inc., Chairman at Health Systems, Inc., Director at Encysive Pharmaceuticals, Inc. from 2001 to 2007, Director at La Jolla Pharmaceutical Co., Independent Director at Onyx Pharmaceuticals, Inc. from 2011 to 2013, Director at Praecis Pharmaceuticals, Inc., Director at Allos Therapeutics, Inc. from 2007 to 2008, Independent Director at Sangamo Therapeutics, Inc. from 2016 to 2018, Director at Inspire Pharmaceuticals, Inc. from 2001 to 2007, Director at Alvine Pharmaceuticals, Inc., Independent Director at Mirati Therapeutics, Inc. from 2014 to 2016, Director at BioCrossroads, Independent Director at Immune Design Corp.
from 2014 to 2019, Independent Director at Dermira, Inc. from 2014 to 2020, President-Infectious Diseases Business Unit at Eli Lilly & Co. from 1973 to 2001, Senior VP-Strategy & Business Development at Pfizer Inc. from 2008 to 2010, Board Member at Portola Pharmaceuticals LLC from 2006 to 2009, Executive Partner at Sofinnova Investments, Inc. from 2010 to 2011, and Vice President-Sales & Marketing at US Pharmaceuticals, Inc. Education includes undergraduate and MBAistration degrees from the University of Dayton.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
10/04/2026 1 455 ( 0,01 % ) 40 245 $ 31/05/2026
21/05/2025 798 ( 0,06 % ) 16 870 $ 31/05/2026

Postes actifs de William Ringo

SociétésPosteDébut
ASSEMBLY BIOSCIENCES, INC. Président 10/02/2015
Directeur/Membre du Conseil 28/04/2011
Directeur/Membre du Conseil 01/06/2021
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 22/05/2017
Encore Retail GP LLC
Directeur/Membre du Conseil 20/03/2014
Private Equity Investor -

Anciens postes connus de William Ringo

SociétésPosteFin
SENSEI BIOTHERAPEUTICS, INC. Président 02/01/2025
FIVE PRIME THERAPEUTICS, INC. Directeur Général 13/04/2020
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de William Ringo

Formation de William Ringo

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

87

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Finance

Finance

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Encore Retail GP LLC

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. William Ringo
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇